financetom
JNJ
financetom
/
Healthcare
/
JNJ
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Johnson & JohnsonJNJ
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide.

The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products.

This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand.

It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension.

This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use.

Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand.

This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Latest News >
Honeywell Automation India's Q1 profit jumps on order execution
Honeywell Automation India's Q1 profit jumps on order execution
Aug 5, 2024
BENGALURU (Reuters) - Engineering firm Honeywell Automation reported higher first-quarter profit on Monday, aided by execution of existing orders. The Indian unit of U.S.-based Honeywell International reported a profit of 1.37 billion rupees (around $16 million), compared to 1.03 billion rupees a year ago. Execution of legacy projects and stable costs helped boost earnings of Honeywell, analysts said. The company...
Market Chatter: US Expected to Propose Chinese Software Ban in Self-Driving Vehicles
Market Chatter: US Expected to Propose Chinese Software Ban in Self-Driving Vehicles
Aug 5, 2024
07:09 AM EDT, 08/05/2024 (MT Newswires) -- The US Commerce Department is planning to propose banning Chinese software in American self-driving vehicles with Level 3 automation and above, Reuters reported Sunday, citing people briefed on the matter. The Biden administration is also expected to propose prohibiting Chinese-developed advanced wireless communications abilities modules from driving on US roads, the report said....
Sonic Automotive Q2 Earnings, Revenue Fall; Announces Quarterly Dividend
Sonic Automotive Q2 Earnings, Revenue Fall; Announces Quarterly Dividend
Aug 5, 2024
07:11 AM EDT, 08/05/2024 (MT Newswires) -- Sonic Automotive ( SAH ) reported Q2 adjusted earnings Monday of $1.47 per diluted share, down from $1.83 a year earlier. Analysts polled by Capital IQ expected $1.38. Revenue for the quarter ended June 30 was $3.45 billion, down from $ 3.65 billion a year earlier. Analysts surveyed by Capital IQ expected $3.56...
Royal Philips Plans to Repurchase Up to $136.8 Million in Shares
Royal Philips Plans to Repurchase Up to $136.8 Million in Shares
Aug 5, 2024
07:10 AM EDT, 08/05/2024 (MT Newswires) -- Royal Philips (PHG) said Monday it will repurchase up to 125 million euros ($136.8 million) in common shares to cover a portion of its obligations under long-term incentive plans. The company estimates the buyback to include about 4.8 million shares based on its current share price. Price: 27.67, Change: -0.81, Percent Change: -2.84...
Copyright 2023-2026 - www.financetom.com All Rights Reserved